1. Medication, Quality of Life and Compliance

   • Mickey C. Smith

   Leading Article 13 November 2012 Pages: 225 - 230

2. Recombinant Granulocyte Colony-Stimulating Factor (rG-CSF)

   • Diana Faulds
   • Nancy J. W. Lewis
   • Richard J. Milne

   Pharmacoeconomics Drug Evaluation 13 November 2012 Pages: 231 - 249

3. A Review of Cost-Effectiveness Analyses of Hypertension Treatment

   • Magnus Johannesson
   • Bengt Jönsson

   Review Article 13 November 2012 Pages: 250 - 264

4. Institutional Formularies

   • Robert J. Lipsy

   Review Article 13 November 2012 Pages: 265 - 281

5. Meta-Analysis and Quality of Evidence in the Economic Evaluation of Drug Trials

   • R. John Simes
   • Paul P. Glasziou

   Review Article 13 November 2012 Pages: 282 - 292

6. Potential Cost Savings of Oral Versus Intravenous Etoposide in the Treatment of Small Cell Lung Cancer

   • Steven Pashko
   • David H. Johnson

   Original Research Article 13 November 2012 Pages: 293 - 297

7. Duodenal Ulcer Disease

   • John B. Marshall

   Current Comment 13 November 2012 Pages: 298 - 299

8. Cost-Effectiveness of Cost-Effectiveness Studies

   • Steven Pashko

   Correspondence 13 November 2012 Pages: 300 - 301